Dear Sir or Madam, The Fraunhofer lighthouse project RNAuto aims to automate the production of mRNA therapeutics in order to manufacture cancer drugs more cost-effectively and economically. Led by Rolf Hendrik van Lengen from Fraunhofer IESE, the project promises to drastically reduce production costs through the use of modular systems, digital quality control and artificial intelligence. With the involvement of seven Fraunhofer Institutes, RNAuto is scheduled for completion by the end of 2025, representing a significant step towards affordable therapies. Find out more about this initiative in our interview with Mr. van Lengen. Discover the most exciting news in medical technology in the COMPAMED magazine! We hope you enjoy exploring our content and wish you an inspiring week Tim Plato Editorial team COMPAMED-tradefair.com
|